India to France: Ezetimibe Export Trade Route

The India to France Ezetimibe corridor is one of India's established pharmaceutical export routes, with 108 shipments documented worth a combined $6.8M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $62.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ezetimibe's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #6 among India's top ezetimibe export destinations globally.

On the import side, key buyers of Indian ezetimibe in France include CSP MYLAN SAS AT CSP LABO 274, CSP VIATRIS SANT? AT CSP- LAB, CSP Mylan SAS at CSP- Labo 274, and 22 others. CSP MYLAN SAS AT CSP LABO 274 is the single largest importer with 8 shipments valued at $1.2M USD.

India's ezetimibe exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 64 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED , ZYDUS LIFESCIENCES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $62.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ezetimibe mylan 10mg 90bl tab pack 58377 and ezetimibe mylan 10 mg 90bl tab (113205 p , suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CSP MYLAN SAS AT CSP LABO 274 is the largest importer with 8 shipments worth $1.2M USD — representing 18% of all ezetimibe imports from India on this route. A total of 25 buyers are active on this corridor.